Fineline Cube

Follow:
14409 Articles
Sihuan Pharmaceutical's Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China
CompanyDeals

Sihuan Pharmaceutical’s Huisheng Pharm Strikes Exclusive Deal for Semaglutide Biosimilar in China

Innovent Biologics' IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment
CompanyDrug

Innovent Biologics’ IBI354 Earns Breakthrough Therapy Designation for Ovarian Cancer Treatment

CDE Includes Double-Crane's Hydroxocobalamine and Sanofi Genzyme's Fitusiran in Rare Disease Care Plan
CompanyDrug

CDE Includes Double-Crane’s Hydroxocobalamine and Sanofi Genzyme’s Fitusiran in Rare Disease Care Plan

Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency
CompanyDrug

Apeiron Therapeutics Initiates Phase Ia/B Study for GTA182 in Solid Tumors with MTAP Deficiency

BI Partners with Sinopharm for Promotion of Sifrol and Pradaxa in China
CompanyDeals

BI Partners with Sinopharm for Promotion of Sifrol and Pradaxa in China

Medtronic Receives US Approval for InPen App with Missed Meal Dose Detection
CompanyMedical Device

Medtronic Receives US Approval for InPen App with Missed Meal Dose Detection

CStone Pharmaceuticals Partners with Pharmalink for Suemalimab Commercialization in MENA and South Africa
CompanyDeals

CStone Pharmaceuticals Partners with Pharmalink for Suemalimab Commercialization in MENA and South Africa

NMPA Approves Alpha Biopharma's Zorifertinib for First-Line NSCLC Treatment with CNS Metastases
CompanyDrug

NMPA Approves Alpha Biopharma’s Zorifertinib for First-Line NSCLC Treatment with CNS Metastases

Pfizer's Hympavzi Receives European Commission Approval for Hemophilia A and B
CompanyDrug

Pfizer’s Hympavzi Receives European Commission Approval for Hemophilia A and B

Guangdong Zhongsheng Pharmaceutical's RAY1225 Shows Positive Results in Phase II Study
CompanyDrug

Guangdong Zhongsheng Pharmaceutical’s RAY1225 Shows Positive Results in Phase II Study

Shenzhen Chipscreen Biosciences Announces Private Placement to Fund Drug R&D and Expansion
CompanyDeals

Shenzhen Chipscreen Biosciences Announces Private Placement to Fund Drug R&D and Expansion

US FDA Grants ODD to Ractigen's siRNA Therapy RAG-21 for ALS Treatment
CompanyDrug

US FDA Grants ODD to Ractigen’s siRNA Therapy RAG-21 for ALS Treatment